Insulin and longevity: antidiabetic biguanides as geroprotectors

Biogerontology - Tập 4 - Trang 297-307 - 2003
Vladimir N. Anisimov1, Anna V. Semenchenko2, Anatoli I. Yashin2
1Department of Carcinogenesis and Oncogerontology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia
2Max Planck Institute for Demographic Research, Rostock, Germany;

Tóm tắt

The results of previous experimental studies of effects of antidiabetic biguanides (phenformin and buformin) on life span and spontaneous tumor incidence in mice and rats were recalculated and reanalyzed using standard demographic models of mortality. The chronic treatment of female C3H/Sn mice with phenformin prolonged the mean life span by 21.1% (P < 0.05), the mean life span of the last 10%survivors by 28.4% and the maximum life span by 5.5 months (by 26%) in comparison with the control. The demographic aging rate represented by the estimate of respective Gompertz's parameter decreased by 31.2% and MRDT increased 1.45-fold. The treatment significantly inhibited (4.0-fold, P < 0.01) the incidence of mammary adenocarcinomas in mice. Administration of phenformin to female LIO rats failed to influence the mean lifespan. At the same time, the mean life span of the last 10% survivors increased by 10.1% (P < 0.05), and maximum life span increased by 3 months (+9.8%). Phenformin attenuated the development of spontaneous tumors in comparison to the control. The treatment of female rats with another antidiabetic biguanide, buformin, slightly increased their mean life span (by 7.3%; P > 0.05). The mean life span of the last 10%survivors increased by 12% (P < 0.05) and the maximum life span increased by 2 months (+5.5%) as compared with controls. The population aging rate decreased by 18.1% (P < 0.05) and MRDT increased 1.22-foldunder the influence of buformin (P < 0.05). The total tumor incidence decreased by 49.5%in buformin-treated rats. Both antidiabetic biguanides slightly decreased the body weight, slowed down the age-related decline of there productive function in female rats. The results of our experiments provide evidence that antidiabetic biguanides are promising geroprotectors as well as drugs which can be used in the prevention of cancer.

Tài liệu tham khảo

Anisimov VN (1980) Effect of buformin and diphenin on life span, estrus function and spontaneous tumor incidence in female rats. Vopr Onkol 26(6): 42-48 Anisimov VN (1982) Effect of phenformin on life span, estrus function and spontaneous tumor incidence in rats. Farmakol Toksikol 45(4): 127 Anisimov VN (1987) Carcinogenesis and Aging, Vol 2. CRC Press, Boca Raton, Florida Anisimov VN, Pliss GB, Iogannsen MG, Popovich IG, Averianova TK, Monakhov AS, Romanov AN and Romanov KP (1989) Spontaneous tumors in outbred LIO rats. J Exp Clin Cancer Res 8: 254-262 Anisimov SV, Volkova MV, Lenskaya LV, Khavinson VKh, Solovieva DV and Schwartz EI (2001) Age-associated accumulation of the Apolipoprotein C-III gene T-455C polymorphism C allele in a Russian population. J Gerontol Biol Sci Med Sci 56A: B27-B32 Awartani KA and Cheung AP (2002) Metformin and polycystic ovary syndrome: a literature review. J Obstet Gynecol Can 24: 393-401 Bakaev VV (2002. Effect of 1-butylbiguanide hydrochloride on the longevity in the nematoda Caenorhabditis elegans. Biogerontology 3(Suppl 1): 23-24 Bartke A and Turyn D (2001) Mechanisms of prolonged longevity: mutants, knock-outs, and caloric restriction. J Anti-Aging Med 4: 197-203 Bartke A, Chandrashekar V, Dominici F, Tutyn D, Kinney B, Steger R and Kopchick JJ (2003) Insulin-like growth factor 1 (IGF01) and aging: controversies and new insights. Biogerontology 4: 1-8 Barzilai N and Gupta G (1999) Interaction between aging and syndrome X: new insights on the pathophysiology of fat distribution. Ann N Y Acad Sci 892: 58-72 Bluher M, Kahn BB and Kahn CR (2003) Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299: 572-574 Bodkin NL, Alexander TM, Ortmeyer HK, Johnson E and Hansen BC (2003) Mortality and morbidity in laboratory-maintained Rhesus monkey and effects of long-term dietary restriction. J Gerontol Biol Sci 58A: 212-219 Clancy DJ, Gems D, Harshman LG, Oldham S, Stocker H, Hafen E, Leevers SJ and Partridge L (2001) Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292: 104-106 Colangelo LA, Gapstur SM, Gann PH, Dyer AR and Liu K (2002) Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 11: 385-391 Coschigano KT, Clemmons D, Bellush LL and Kopchick JJ (2000) Assessment of growth parameters and life span of GHR/BP genedisrupted mice. Endocrinology 141: 2608-2613 Cox DR and Oakes D (1996) Analysis of Survival Data. Chapman &; Hall, London Dilman VM (1994) Development, Aging and Disease. A New Rationale for an Intervention. Harwood Academic Publishers, Chur Dilman VM (1971) Age-associated elevation of hypothalamic threshold to feedback control and its role in development, aging and disease. Lancet 1: 1211-1219 Dilman VM (1978) Ageing, metabolic immunodepression and carcinogenesis. Mech Ageing Dev 8: 153-173 Dilman VM and Anisimov VN (1979) Hypothalamic mechanisms of ageing and of specific age pathology - I. Sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in the reproductive system. Exp Gerontol 14: 161-173 Dilman VM and Anisimov VN (1980) Effect of treatment with phenofromin, dyphenylhydantoin or L-DOPA on life span and tumor incidence in C3H/Sn mice. Gerontology 26: 241-245 Dilman VM, Bobrov JF, Ostroumova MN, Lvovich EG, Vishnevsky AS, Anisimov VN and Vasiljeva IA (1979a) Hypothalamic mechanisms of ageing and of specific age pathology - III. Sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in energy system. Exp Gerontol 14: 217-224 Dilman VM, Ostroumova MN and Tsyrlina EV (1979b) Hypothalamic mechanisms of ageing and of specific age pathology - II. Sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in energy system. Exp Gerontol 14: 175-181 Dilman VM, Berstein LM, Ostroumova MN, Fedorov SN, Poroshina TE, Tsyrlina EV, Buslaeva VP, Semiglazov VF, Seleznev IK, Bobrov YuF, Vasilieva IA, Kondratiev VB, Nemirovsky VS and Nikiforov YF (1982) Metabolic immunodepression and metabolic immunotherapy: an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances. Oncology 39: 13-19 Dilman VM, Berstein LM, Yevtushenko TP, Tsyrlina YV, Ostroumova MN, Bobrov YuF, Revskoy SYu, Kovalenko IG and Simonov NN (1988) Preliminary evidence on metabolic rehabilitation in cancer patients. Arch Geschwulstforsch 58: 175-183 Dominici FP, Arosegui Diaz G, Bartke A, Kopchik JJ and Turyn D (2000) Compensatory alterations of insulin signal transduction in liver of growth hormone receptor knockout mice. J Endocrinol 166: 579-590 Dominici FP, Hauck S, Argention DP, Bartke A and Turyn D (2002) Increased insulin senisitivity and upregulation of insulin receptor, insulin receptor substrate (ISR)-1 and IRS-2 in liver of Ames dwarf mice. J Endocrinol 173: 81-94 Elahi D, Muller DC, Egan JM, Andres R, Veldhuist J and Meneilly GS (2002) Glucose tolerance, glucose utilization and insulin secretion in aging. Novartis Found Symp 242: 222-242 Facchini FS, Hua NW, Reaven GM and Stoohs RA (2000a) Hyperinsulinemia: the missing link among oxidative stress and agerelated diseases? Free Radic Biol Med 29: 1302-1306 Facchini FS, Humphreys MH, Abbasi F, DoNascimento CA and Reaven GM (2000b) Relation between insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and tocopherols. Am J Clin Nutr 72: 776-779 Facchini FS, Hua N, Abbasi F and Reaven GM(2001) Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 86: 3574-3578 Fernandes ML, Saad MJ and Velloso LA (2001) Effect of age on elements of insulin-signaling pathway in central nervous system of rats. Endocrine 16: 227-234 Flurkey K, Papaconstantinou J, Miller RA and Harrison DE (2001) Life-span extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci USA 98: 6736-6741 Gargiulo P, Caccese D, Pignatelli P, Brufani C, De Vito F, Marino R, Lauro R, Violi F, Di Mario U and Sanguigni V (2002) Metformin decreases platelet superoxide anion production in diabetic patients. Diabetes Metab Res Rev 18: 156-159 Gauss System and Graphic Manual (1994) Aptech Systems, Inc, Maple Valley Goubler EV (1978) Computing Methods of Pathology Analysis and Recognition. Leningrad, Meditsina Gupta K, Krishnaswamy G, Karnad A and Peiris AN (2002) Insulin: a novel factor in carcinogenesis. Am J Med Sci 323: 140-145 Hadley EC, Dutta C, Finkelstein J, Harris TB, Lane MA, Roth GS, Sherman SS and Starke-Reed PE (2001) Human implications of caloric restriction's effect on laboratory animals: an overview of opportunities for research. J Gerontol Ser A 56A (special issue I): 5-6 Holzenberger M, Dupond J, Ducos B, Leneuve P, Gefoen A, Even PC, Cervera P and Le Bouc Y (2003) IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421: 182-187 Hsieh CC, DeFord JH, Flurkey K, Harrison DE and Papaconstantinou J (2002a) Implications for the insulin signaling pathway in Snell dwarf mouse longevity: a similarity with the C. elegans longevity paradigm. Mech Ageing Dev 123: 1229-1244 Hsieh CC, DeFord JH, Flurkey K, Harrison DE and Papaconstantinou J (2002b) Effects of the Pit1 mutation on the insulin signaling pathway: implications on the longevity of the longlived Snell dwarf mouse. Mech Ageing Dev 123: 1245-1255 Ikeno Y, Bronson RT, Hubbard GB, Lee S and Bartke A (2003) Delayed occurrence of fatal neoplastic diseases in Ames dwarf mice: correlation to extended longevity. J Gerontol A Biol Sci Med Sci 58: B291-B296 Kenyon C (2001) A conserved regulatory system for aging. Cell 105: 165-168 Lane MA, Tilmont EM, De Angelis H, Handy A, Ingram DK, Kemnitz JW and Roth GS (2000) Short-term calorie restriction improves disease-related markers in older male rhesus monkeys (Macaca mulatta). Mech Ageing Dev 112: 185-196 Lee IM, Blair SN, Allison DB, Folsom AR, Harris TB, Manson JE and Wing RR (2001) Epidemiologic data on the relationships of caloric intake, energy balance, and weight gain over the life span with longevity and morbidity. J Gerontol A Biol Sci Med Sci 56 Spec No. 1: 7-19 Lee J, Chan SL, Lu C, Lane MA and Mattson MP (2002) Phenformin supresses calcium responses to glutamaye and protects hippocampal neurons against excitotoxicity. Exp Neurol 175: 161-167 Longo VD and Finch CE (2003) Evolutionary medicine: from dwarf model systems to healthy centenarians? Science 299: 1342-1346 Lund J, Tedesco P, Duke K, Wang J, Kim SK and Johnson TE (2002) Transcriptional profile of aging in C. elegans. Curr Biol 12: 1566-1573 Masoro EJ (2000) Caloric restriction and ageing: an update. Exp Gerontol 35: 299-305 Mattson MP (2002) Brain evolution and lifespan regulation: conservation of signaling trnsduction pathways that regulate energy metabolism. Mech Ageing Dev 123: 947-953 Mattson MP, Duan W, Lee J, Guo Z, Roth GS, Ingram DK and Lane MA (2001) Progress in the development of caloric restriction mimetic dietary supplements. J Anti-Aging Med 4: 225-232 Mattson MP, Duan W and Maswood N (2002) How does the brain control lifespan? Ageing Res Rev 1: 155-165 Mattson JA, Lane MA, Roth GS and Ingram DK (2003) Calorie restriction in rhesus monkeys. Exp Gerontol 38: 35-46 McCarty MF (1994) Longevity effect of chromium picolinate - 'rejuvenation' of hypothalamic function? Med Hypotheses 3: 253-265 Muntoni S (1974) Inhibition of fatty acid oxidation by biguanides: implication for metabolic physiopathology. Adv Lipid Res 12: 311-377 Muntoni S (1999) Metformin and fatty acids. Diabetes Care 22: 179-180 Nestler JE, Stovall D, Akhther N, Iorno MJ and Jakubowicz DJ (2002) Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril 77: 209-215 Ramsey JJ, Harper M-E and Weindruch R (2000) Restriction of energy intake, energy expenditure, and aging. Free Radic Biol Med 29: 946-968 Roth GS, Ingram DK and Lane MA (1999) Calorie restriction in primates: will it work and how will we know? J Am Geriatr Soc 46: 869-903 Roth GS, Lane MA, Ingram DK, Mattison JA, Elahi D, Tobin JD, Muller D and Metter EJ (2002) Biomarkers of caloric restriction may predict longevity in humans. Science 297: 811 Schneider MB, Matsuzaki H, Harorah J, Ulrich A, Standlop J, Ding XZ, Adrian TE and Pour PM (2001) Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology 120: 1263-1270 Shimokawa I, Higami Y, Utsuyama M, Tuchiya T, Komatsu T, Chiba T and Yamaza H (2002) Life span extension by reducing in growth hormone-insulin-growth factor-1 axis in a transgenic rat model. Am J Pathol 160: 2259-2265 Tatar M, Kopelman A, Epstein D, Tu MP, Yin CM and Garofalo RS (2001) A mutant Drosophila insulin receptor homologue that extends life-span and impairs neuroendocrine function. Science 292: 107-110 Tatar M, Bartke A and Antebi A (2003) The endocrine regulation of aging by insulin-like signals. Science 299: 1346-1351 Ulrich P and Cerami A (2001) Protein glycation, diabetes, and aging. Recent Prog Horm Res 56: 1-21 Verzijl N, DeGroot J, Bank RA, Bayliss MT, Bijlsma JW, Lafeber FE, Maroudas A and TeKoppele JM (2001) Age-related accumulation of the advanced glycation end product pentosidine in human articular cartilage aggrecan: the use of pentosidine levels as a quantitative measure of protein turnover. Matrix Biol 20: 409-417 Weindruch R and Walford R (1988) The Retardation of Aging and Disease by Dietary Restriction. CC. Thomas, Springfield, Illinois Weindruch R, Keenan KP, Carney JM, Fernandes G, Feuers RJ, Halter JB, Ramsey JJ, Richardson A, Roth GS and Spindler SR (2001) Caloric restriction mimetics: metabolic intervention. J Gerontol A Biol Sci Med Sci 56A, special issue 1: 20-33